8WK Stock Chart & Stats
€0.56
<€0.01(0.88%)
At close: 4:00 PM EST
€0.56
<€0.01(0.88%)
Day’s Range― - ―
52-Week Range€0.44 - €0.97
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€16.43M
Enterprise Value€7.80M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding20,498,950
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
8WK FAQ
What was Abera Bioscience AB’s price range in the past 12 months?
Abera Bioscience AB lowest stock price was €0.44 and its highest was €0.97 in the past 12 months.
What is Abera Bioscience AB’s market cap?
Abera Bioscience AB’s market cap is €16.43M.
When is Abera Bioscience AB’s upcoming earnings report date?
Abera Bioscience AB’s upcoming earnings report date is Aug 20, 2026 which is in 25 days.
How were Abera Bioscience AB’s earnings last quarter?
Abera Bioscience AB released its earnings results on May 12, 2026. The company reported -€0.026 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.026.
Is Abera Bioscience AB overvalued?
According to Wall Street analysts Abera Bioscience AB’s price is currently Overvalued.
Does Abera Bioscience AB pay dividends?
Abera Bioscience AB does not currently pay dividends.
What is Abera Bioscience AB’s EPS estimate?
Abera Bioscience AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Abera Bioscience AB have?
Abera Bioscience AB has 20,498,950 shares outstanding.
What happened to Abera Bioscience AB’s price movement after its last earnings report?
Abera Bioscience AB reported an EPS of -€0.026 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.857%.
Which hedge fund is a major shareholder of Abera Bioscience AB?
Currently, no hedge funds are holding shares in DE:8WK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Abera Bioscience AB
Abera Bioscience AB is a platform and vaccine development company based on research in the medical, molecular, and microbiological fields. The company's mission is to develop vaccine candidates based on its novel vaccine delivery platform to late pre-clinical or early clinical phase.